Comprehension of affective prosody in multiple sclerosis

Multiple Sclerosis

Volumn 9, Issue 2, 2003, Pages 148-153

  Beatty, William W ^a,c   Orbelo, Diana M ^b,c   Sorocco, Kristen H ^c   Ross, Elliott D ^a,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Affect comprehension; Demyelinating disease; Emotion; Multiple sclerosis

Indexed keywords

ANTIDEPRESSANT AGENT; IMMUNOMODULATING AGENT; MUSCLE RELAXANT AGENT; SPASMOLYTIC AGENT; CENTRAL MUSCLE RELAXANT; IMMUNOLOGICAL ADJUVANT;

ADULT; APHASIA; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; COMPREHENSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DEMYELINATING DISEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EMOTIONAL DISORDER; FATIGUE; FEMALE; HEARING LOSS; HEARING TEST; HUMAN; INFORMED CONSENT; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PHONETICS; PHYSICAL DISABILITY; SOCIAL INTERACTION; SPEECH DISORDER; SPEECH THERAPY; STROKE; DISABILITY; EMOTION; MIDDLE AGED; PERCEPTION DEAFNESS; PERCEPTIVE DISCRIMINATION; SPEECH; SPEECH PERCEPTION;

ADJUVANTS, IMMUNOLOGIC; ADULT; AUDITORY PERCEPTUAL DISORDERS; DISABILITY EVALUATION; DISCRIMINATION (PSYCHOLOGY); EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE RELAXANTS, CENTRAL; SPEECH ACOUSTICS; SPEECH PERCEPTION;

EID: 0037356712     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458503ms897oa     Document Type: Article

References (24)

1. Rao SM, Leo GJ, Bernardin L, Univerzagt F Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-91.
2. Beaty WW. Cognitive and emotional disturbances in multiple sclerosis. Neurol Clin 1993; 11: 189-204.
3. Beatty WW, Goodkin DE, Weir WS, Staton RD, Monson N, Beatty PA. Affective judgments by patients with Parkinson's disease or chronic progressive multiple sclerosis. Bull Psychon Soc 1989; 27: 361-64.
4. Ross ED, Thompson R, Yenkosky J. Lateralization of affective prosody in brain and callosal integration of hemispheric language functions. Brain Lang 1997; 56: 27-54.
5. Blonder LX, Gur RE, Gur RC. The effects of right and left hemiparkinsonism on prosody. Brain Lang 1989; 36: 193-207.
6. Benke T, Bösch S, Andree B. A study of emotional processing on Parkinson's disease. Brain Cogn 1998; 38: 36-52.
7. Speedie LJ, Brake N, Folstein SF, Bowers D, Heilman KM. Comprehension of prosody in Huntington's disease. J Neurol Neurosurg Psychiatry 1990; 53: 607-10.
8. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis F, Ebers GC et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
9. Testa JA, Beatty WW, Gleason A, Orbelo DM, Ross ED. Impaired affective prosody in Alzheimer's disease: Relationship to aphasic deficits and emotional behaviors. Neurology 2001; 57: 1474-81.
10. Monnot M, Nixon S, Lovallo W, Ross ED. Altered emotional perception in alcoholics: Deficits in affective prosodic comprehension. Alcohol Clin Exp Res 2001; 25: 362-69.
11. Monnot M, Lovallo W, Nixon S, Ross ED. Neurological basis of deficits in affective prosody comprehension among alcoholics and fetal alcohol exposed adults. J Neuropsychiatry Clin Neurosci 2002; 14: 321-28.
12. Ross ED, Orbelo DM, Cartwright J, Hansel S, Burgard M, Testa JA et al. Affective prosodic deficits in schizophrenia: Profiles of patients with brain damage and relation to schizophrenic symptoms. J Neurol Neurosurg Psychiatry 2001; 70: 597-604.
13. Orbelo DM, Testa JA, Ross ED. Age-related impairments in comprehending affective prosody: Comparison to brain damaged subjects. J Geriatr Psychiatry Neurol 2002; in press.
14. Folstein MF, Folstein SE, McHugh PR. 'Mini Mental State': A practical method of grading the cognitive state of patients for the clinician. J Psychiatry 1975; 12: 189-96.
15. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
16. Kertesz A. Western Aphasia Battery. New York: Grune & Stratton, 1982.
17. Beck AT, Steer RA, Brown GK. Beck Depression Inventory, Second Edition. San Antonio, TX: Psychological Corporation, 1996.
18. Randolph C. Repeatable Battery for the Assessment of Neuropsychological Status. San Antonio, TX: Psychological Corporation, 1998.
19. Randolph C, Tierney MD, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. J Clin Exp Neuropsychol 1998; 20: 310-19.
20. Beaty WW, Ryder KA, Gontkovsky ST, Scott JG, McSwan KL, Bharucha KJ. Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS. Arch Clin Neuropsychol 2002; in press.
21. Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD et al. Intensive immunosuppression in progressive multiple sclerosis. N Engl J Med 1983; 308: 173-80.
22. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
23. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unversagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991; 41: 692-96.
24. Rovaris M, Comi G, Filippi M. The role of non-conventional MR techniques to study multiple sclerosis patients. J Neurol Sci 2001; 186: S3-S9.